Emergency -

University of South Florida

COVID Vaccine Patient Information

COVID Vaccine Patient Information 

USF Health is now able to provide COVID-19 vaccinations to eligible USF Health patients. Per Executive Order* by Florida Gov. Ron DeSantis, USF Health will only provide COVID-19 vaccines as follows:

“…During this first phase of vaccine administration, all providers administering any COVID-19 vaccine shall only vaccinate the following populations:
· Long-term care facility residents and staff;
· Persons 65 years of age and older; and
· Health care personnel with direct patient contact. Hospital providers, however, also may vaccinate persons who they deem to be extremely vulnerable to COVID-19.” 

Appointments are required to receive a COVID-19 vaccine through USF Health. If current patients meet the criteria above, you will be notified by email from USF Health providing more details.

*Here is more information on the Executive Order.

At USF Health, our priority is the health and safety of our patients and their families. We are closely monitoring the coronavirus (COVID-19) outbreak and are following the official recommendations provided by local and state departments of health.

During this time of uncertainty, we understand that the current COVID-19 crisis and the given local risk in Hillsborough County are concerning to many of our patients who are receiving care at our clinical locations. We are committed to improving health in the safest manner possible, and our health care providers are diligently working to take the necessary steps to safely provide critical clinical services to our patients and their families while protecting our staff.

COVID-19 Testing

USF Health currently offers the following COVID-19 tests. Your provider will determine which test is best for you based on your clinical symptoms and test kit availability.

While most insurance covers the cost of testing for COVID-19, those who don’t have insurance or who choose to self-pay can expect the following costs.

Antigen test: Infectious agent antigen detection by immunoassay technique, (e.g., enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative or semiquantitative, multiple-step method; 87426 severe acute respiratory syndrome coronavirus (e.g., SARS-CoV, SARS-CoV-2 [COVID-19]: $150 self-pay cost

Molecular test: Infectious agent detection by nucleic acid (DNA or RNA); 87635 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique: $154 self-pay cost

 

USF Health Making Life Better

 

Copy link
Powered by Social Snap